BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8530363)

  • 1. Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment.
    Avidor-Reiss T; Bayewitch M; Levy R; Matus-Leibovitch N; Nevo I; Vogel Z
    J Biol Chem; 1995 Dec; 270(50):29732-8. PubMed ID: 8530363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supersensitization of the adenylyl cyclase system in Chinese hamster ovary cells co-expressing cloned opioid receptors and Gz, a PTX-insensitive G protein.
    Ozawa T; Nakagawa T; Minami M; Satoh M
    Neurosci Lett; 1999 May; 267(2):117-20. PubMed ID: 10400226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediation of adenylyl cyclase sensitization by PTX-insensitive GalphaoA, Galphai1, Galphai2 or Galphai3.
    Clark MJ; Traynor JR
    J Neurochem; 2006 Dec; 99(6):1494-504. PubMed ID: 17230639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
    Liu JG; Prather PL
    Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptations to chronic agonist exposure of mu-opioid receptor-expressing Chinese hamster ovary cells.
    Kato S; Fukuda K; Morikawa H; Shoda T; Mima H; Mori K
    Eur J Pharmacol; 1998 Mar; 345(2):221-8. PubMed ID: 9600641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential opioid agonist regulation of the mouse mu opioid receptor.
    Blake AD; Bot G; Freeman JC; Reisine T
    J Biol Chem; 1997 Jan; 272(2):782-90. PubMed ID: 8995364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells.
    Piros ET; Prather PL; Loh HH; Law PY; Evans CJ; Hales TG
    Mol Pharmacol; 1995 May; 47(5):1041-9. PubMed ID: 7746271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gbetagamma.
    Avidor-Reiss T; Nevo I; Levy R; Pfeuffer T; Vogel Z
    J Biol Chem; 1996 Aug; 271(35):21309-15. PubMed ID: 8702909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A molecular mechanism for supersensitization of adenylyl cyclase system in cloned opioid receptor-transfected cells following sustained opioid treatment].
    Nakagawa T; Ozawa T; Watanabe T; Minami M; Satoh M
    Nihon Yakurigaku Zasshi; 1998 Oct; 112 Suppl 1():78P-82P. PubMed ID: 10190139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling.
    Yabaluri N; Medzihradsky F
    Mol Pharmacol; 1997 Nov; 52(5):896-902. PubMed ID: 9351981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cyclic AMP by the mu-opioid receptor in human neuroblastoma SH-SY5Y cells.
    Yu VC; Eiger S; Duan DS; Lameh J; Sadée W
    J Neurochem; 1990 Oct; 55(4):1390-6. PubMed ID: 1697894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
    Noble F; Cox BM
    Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of type II adenylyl cyclase by the cloned mu-opioid receptor: coupling to multiple G proteins.
    Chan JS; Chiu TT; Wong YH
    J Neurochem; 1995 Dec; 65(6):2682-9. PubMed ID: 7595566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of recombinant rat mu-opioid receptor activation in CHO cells on phospholipase C, [Ca2+]i and adenylyl cyclase.
    Smart D; Hirst RA; Hirota K; Grandy DK; Lambert DG
    Br J Pharmacol; 1997 Mar; 120(6):1165-71. PubMed ID: 9134231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroblastoma Neuro2A cells stably expressing a cloned mu-opioid receptor: a specific cellular model to study acute and chronic effects of morphine.
    Chakrabarti S; Law PY; Loh HH
    Brain Res Mol Brain Res; 1995 Jun; 30(2):269-78. PubMed ID: 7637578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
    Yoshimura M; Ikeda H; Tabakoff B
    Mol Pharmacol; 1996 Jul; 50(1):43-51. PubMed ID: 8700117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial agonistic activity of naloxone on the opioid receptors expressed from complementary deoxyribonucleic acids in Chinese hamster ovary cells.
    Fukuda K; Kato S; Shoda T; Morikawa H; Mima H; Mori K
    Anesth Analg; 1998 Aug; 87(2):450-5. PubMed ID: 9706949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
    Clark MJ; Traynor JR
    J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic morphine treatment increases stimulatory beta-2 adrenoceptor signaling in A431 cells stably expressing the mu opioid receptor.
    Ammer H; Schulz R
    J Pharmacol Exp Ther; 1997 Jan; 280(1):512-20. PubMed ID: 8996236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endomorphins fully activate a cloned human mu opioid receptor.
    Gong J; Strong JA; Zhang S; Yue X; DeHaven RN; Daubert JD; Cassel JA; Yu G; Mansson E; Yu L
    FEBS Lett; 1998 Nov; 439(1-2):152-6. PubMed ID: 9849897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.